AIM
ADMA icon

Aigen Investment Management’s ADMA Biologics ADMA Stock Holding History

Aigen Investment Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$101K Buy
+11,212
New +$177K 0.03% 466
2025
Q1 		– Sell
-29,513
Closed -$506K – 735
2024
Q4 		$506K Buy
29,513
+370
+1% +$6.96K 0.09% 327
2024
Q3 		$583K Buy
+29,143
New +$453K 0.11% 275
2023
Q4 		– Sell
-39,052
Closed -$140K – 763
2023
Q3 		$140K Buy
+39,052
New +$150K 0.03% 717
2020
Q3 		– Sell
-29,691
Closed -$87K – 833
2020
Q2 		$87K Buy
+29,691
New +$85.3K 0.01% 766

Other funds holding ADMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return